SIS
VRTX icon

Strategic Investment Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Strategic Investment Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Hold
58
– – 0.01% 313
2026
Q1 		$25.9K Hold
58
– – 0.01% 312
2025
Q4 		$26.3K Hold
58
– – 0.01% 294
2025
Q3 		$22.7K Buy
58
+38
+190% +$15.9K 0.01% 285
2025
Q2 		$8.9K Hold
20
– – ﹤0.01% 375
2025
Q1 		$9.7K Hold
20
– – ﹤0.01% 370
2024
Q4 		$8.05K Buy
+20
New +$9.27K ﹤0.01% 406

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Strategic Investment Solutions's VRTX Position: Q2 2026 in Review

Strategic Investment Solutions held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 58 shares worth $28.8K. The position accounts for 0.01% of the portfolio, ranked #313.

Strategic Investment Solutions first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 368 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Strategic Investment Solutions held 58 shares of Vertex Pharmaceuticals worth $28.8K as of Q2 2026.
  • Strategic Investment Solutions left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #313 holding.
  • Strategic Investment Solutions first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 368 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.